TY - JOUR
T1 - N‐monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensives.
AU - Montamat, SC
AU - Abernethy, DR
PY - 1987/8
Y1 - 1987/8
N2 - 1 Twelve young (ages 30‐39 years) and twelve elderly (ages 65‐83 years) hypertensives were administered diltiazem twice daily for 2 weeks at doses up to 240 mg day‐1. 2 Plasma was analysed for diltiazem, N‐ monodesmethyldiltiazem, and desacetyldiltiazem concentrations after a single 10 min intravenous infusion of 21.8 mg diltiazem HCl on day 1 and after the morning oral dose of 120 mg diltiazem base on day 14. 3 N‐ monodesmethyldiltiazem accumulated to higher plasma concentrations than desacetyldiltiazem at steady state on day 14 in both age groups. 4 Prolongation of plasma diltiazem half‐life occurred after 2 weeks of oral diltiazem therapy in both age groups. 5 There were no significant differences between the young and elderly with regard to half‐life, area under the curve, and the peak and trough plasma concentrations of diltiazem, N‐monodesmethyldiltiazem, and desacetyldiltiazem; systemic clearance and volume of distribution of diltiazem were also similar in both groups. 1987 The British Pharmacological Society
AB - 1 Twelve young (ages 30‐39 years) and twelve elderly (ages 65‐83 years) hypertensives were administered diltiazem twice daily for 2 weeks at doses up to 240 mg day‐1. 2 Plasma was analysed for diltiazem, N‐ monodesmethyldiltiazem, and desacetyldiltiazem concentrations after a single 10 min intravenous infusion of 21.8 mg diltiazem HCl on day 1 and after the morning oral dose of 120 mg diltiazem base on day 14. 3 N‐ monodesmethyldiltiazem accumulated to higher plasma concentrations than desacetyldiltiazem at steady state on day 14 in both age groups. 4 Prolongation of plasma diltiazem half‐life occurred after 2 weeks of oral diltiazem therapy in both age groups. 5 There were no significant differences between the young and elderly with regard to half‐life, area under the curve, and the peak and trough plasma concentrations of diltiazem, N‐monodesmethyldiltiazem, and desacetyldiltiazem; systemic clearance and volume of distribution of diltiazem were also similar in both groups. 1987 The British Pharmacological Society
UR - http://www.scopus.com/inward/record.url?scp=0023220353&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023220353&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2125.1987.tb03160.x
DO - 10.1111/j.1365-2125.1987.tb03160.x
M3 - Article
C2 - 3620292
AN - SCOPUS:0023220353
SN - 0306-5251
VL - 24
SP - 185
EP - 189
JO - British Journal of Clinical Pharmacology
JF - British Journal of Clinical Pharmacology
IS - 2
ER -